INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/05/2026
Back to search
Official data from USPTO
KYRUNVU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
08/05/2026
Trademark type
Word
Nice classes
5
Filing date
09/03/2018
Registration date
05/21/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2025
Last transaction
08/05/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
MORAN, CAROLINE L
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
IWASE Hitomi
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
Publications
History of USPTO decisions and trademark events.
17 publications found
C71T
CANCELLED SECTION 71
12/05/2025
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
09/23/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/04/2025
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/16/2019
FIMP
FINAL DISPOSITION PROCESSED
07/16/2019
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
06/20/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2019
PUBO
PUBLISHED FOR OPPOSITION
03/05/2019
NPUB
NOTICE OF PUBLICATION
02/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/19/2019
DOCK
ASSIGNED TO EXAMINER
01/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/14/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/10/2019
Continuous trademark protection
Get notified about every new filing that threatens KYRUNVU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.